Use of mcrp for delivery of materials into cells
CA 2341309 A1 · Owner: Immtech International Inc. · Inventors: Potempa, Lawrence A.; Diehl, Edward E.; Radosevich, James A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a method of delivering a material into a cell. The method comprises associating the material with a modified C-reactive protein (mCRP) or a mutant-mCRP. Then, the material associated with the mCRP or the mutant-mCRP is contacted with the cell so that the material is delivered into the cell. The invention also provides a kit comprising one or more containers. In one embodiment, one of the containers holds a material to be delivered into a cell in association with a modified C-reactive protein (mCRP) or a mutantmCRP. Alternatively, one of the containers holds the material to be delivered into the cell, and a second container holds the mCRP or the mutant-mCRP.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 19, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 19, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 19, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.